Clinical Trials Browser

Phase 1/2 × sitravatinib × Genitourinary × Clear all

NCT03015740 2024-11-19

Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer

Phase 1/2 Completed

42 enrolled 14 charts

Carcinoma, Renal Cell